These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31189513)

  • 1. Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening.
    Téllez T; Abitei C; Padilla-Ruiz MDC; Rivas-Ruiz F; Fúnez R; Pereda T; Rodrigo I; Alcaide J; Baré ML; Morales Suárez-Varela MM; Zabalza I; Sánchez Del Charco M; Borrero Martín JJ; García Del Moral R; Escobar A; Quintana JM; Aguirre U; Redondo M;
    Eur J Surg Oncol; 2019 Oct; 45(10):1876-1881. PubMed ID: 31189513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours.
    Redondo M; Abitei C; Téllez T; Fúnez R; Pereda T; Rodrigo I; Betancourt AM; García-Aranda M; Rueda A; Martínez García RC; Morales Suarez-Varela MM; Zabalza I; Sánchez Del Charco M; Borrero Martín JJ; García Del Moral R; Escobar A; Quintana J; Rivas-Ruiz F;
    Tumour Biol; 2019 Apr; 42(4):1010428319835684. PubMed ID: 30957671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based screening improves histopathological prognostic factors in colorectal cancer.
    Mengual-Ballester M; Pellicer-Franco E; Valero-Navarro G; Soria-Aledo V; García-Marín JA; Aguayo-Albasini JL
    Int J Colorectal Dis; 2018 Jan; 33(1):23-28. PubMed ID: 29138933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased survival and decreased recurrence in colorectal cancer patients diagnosed in a screening programme.
    Mengual-Ballester M; Pellicer-Franco E; Valero-Navarro G; Soria-Aledo V; García-Marín JA; Aguayo-Albasini JL
    Cancer Epidemiol; 2016 Aug; 43():70-5. PubMed ID: 27399311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
    Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
    Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of colorectal cancer screening in a veteran hospital population.
    Trombold J; Farmer RW; McCafferty M
    Am Surg; 2013 Mar; 79(3):296-300. PubMed ID: 23461957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests.
    van Rossum LG; van Rijn AF; van Munster IP; Jansen JB; Fockens P; Laheij RJ; Dekker E
    Neth J Med; 2009 May; 67(5):182-6. PubMed ID: 19581668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen-detected colorectal cancers show improved cancer-specific survival when compared with cancers diagnosed via the 2-week suspected colorectal cancer referral guidelines.
    Courtney ED; Chong D; Tighe R; Easterbrook JR; Stebbings WS; Hernon J
    Colorectal Dis; 2013 Feb; 15(2):177-82. PubMed ID: 22709315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening-detected colorectal cancers show better long-term survival compared with stage-matched symptomatic cancers.
    Cienfuegos JA; Baixauli J; Martínez Ortega P; Valentí V; Martínez Regueira F; Martí-Cruchaga P; Zozaya G; Hernández Lizoain JL
    Rev Esp Enferm Dig; 2018 Nov; 110(11):684-690. PubMed ID: 30032629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
    Idigoras Rubio I; Arana-Arri E; Portillo Villares I; Bilbao Iturribarrria I; Martínez-Indart L; Imaz-Ayo N; de la Cruz M; de Castro V; López de Munain A; Torrejón Perez I; Gutiérrez-Ibarluzea I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):197-204. PubMed ID: 30543575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
    Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
    Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas.
    Gandhi JS; Goswami M; Sharma A; Tanwar P; Gupta G; Gupta N; Pasricha S; Mehta A; Singh S; Agarwal M; Gupta N
    J Gastrointest Cancer; 2018 Dec; 49(4):406-414. PubMed ID: 28585041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancers detected through screening are associated with lower stages and improved survival.
    Lindebjerg J; Osler M; Bisgaard C
    Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [National population screening for colorectal carcinoma in the Netherlands: results of the first years since the implementation in 2014].
    Elferink MAG; Toes-Zoutendijk E; Vink GR; Lansdorp-Vogelaar I; Meijer GA; Dekker E; Lemmens VEPP
    Ned Tijdschr Geneeskd; 2018; 162():D2283. PubMed ID: 29519262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting.
    Werner S; Krause F; Rolny V; Strobl M; Morgenstern D; Datz C; Chen H; Brenner H
    Clin Cancer Res; 2016 Apr; 22(7):1725-33. PubMed ID: 26561557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a colorectal cancer screening programme: results from a single-centre study.
    Vermeer NCA; Bahadoer RR; Bastiaannet E; Holman FA; Meershoek-Klein Kranenbarg E; Liefers GJ; van de Velde CJH; Peeters KCMJ
    Colorectal Dis; 2018 Sep; 20(9):O239-O247. PubMed ID: 29917325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.
    Idigoras I; Arrospide A; Portillo I; Arana-Arri E; Martínez-Indart L; Mar J; de Koning HJ; Lastra R; Soto-Gordoa M; van der Meulen M; Lansdorp-Vogelaar I
    BMC Public Health; 2017 Aug; 18(1):78. PubMed ID: 28764731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an organised population screening programme for colorectal cancer: Measurement after first and second rounds.
    Mar J; Arrospide A; Larrañaga I; Iruretagoiena ML; Imaz L; Gorostiza A; Ibarrondo O
    J Med Screen; 2021 Jun; 28(2):122-130. PubMed ID: 32380931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
    Ambe PC; Jansen S; Zirngibl H
    World J Surg Oncol; 2017 Aug; 15(1):159. PubMed ID: 28835275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.